Washington Manual of Medical Therapeutics
- P2Y12 inhibitor
- Pacing modes
- Packed RBCs (pRBCs) transfusion
- Paget disease
- Pain
- Painful peripheral neuropathy
- Palpitations
- Pancreatic cancer
- Pancreatic diabetes
- Pancreatic enzyme supplements, chronic pancreatitis
- Pancreatic insufficiency
- Pancreaticobiliary disorders
- Pancreatitis
- Pancytopenia
- Pantothenic acid [table]
- Papillary muscle rupture
- Papillary serous adenocarcinoma of unknown primary
- Paracentesis
- Parasitic infection, graft rejection
- Parathyroid hormone (PTH)
- Parenteral iron therapy
- Parenteral solutions [table]
- Parenteral vasodilators
- Passive immunization
- Patient-controlled analgesia pump
- PCSK9 inhibitors
- Peak airway pressure
- Pectin, diarrhea
- Pegloticase [table]
- Pegvisomant
- Pegylated IFNs
- Penicillamine
- Penicillin allergy
- Pentoxifylline
- Peppermint oil
- Peptic ulcer disease (PUD)
- Percutaneous balloon angioplasty (BPA)
- Percutaneous cholecystostomy, gallstone disease
- Percutaneous mitral balloon commissurotomy (PMBC)
- Percutaneous pericardiocentesis
- Percutaneous transhepatic cholangiography (PTC), liver disease
- Perianal neoplasia
- Periarthritis
- Pericardial disease
- Pericardial friction rub
- Pericardial space
- Pericardial window
- Pericarditis
- Perindopril [table]
- Perioperative anticoagulation
- Peripartum cardiomyopathy (PPCM)
- Peripheral inflammatory arthritis
- Peripheral vascular disease (PVD)
- Perirectal abscess
- Peritonsillar abscess
- Permanent pacing
- Petechiae
- Pharmacologic prophylaxis
- Pharmacologic stress testing
- Pharyngitis
- Phencyclidine (PCP)
- Phenothiazines
- pH impedance monitoring, gastroesophageal reflux disease (GERD)
- Phlebotomy
- Phosphate, diabetic ketoacidosis (DKA) [table]
- Phosphate restriction, chronic kidney disease (CKD)
- Phosphodiesterase-4 (PDE4) inhibitors
- Phosphodiesterase-5 inhibitors
- Phospholipids
- Phylloquinone [table]
- Piecemeal necrosis
- Pigment nephropathy
- Pindolol [table]
- Pioglitazone [table]
- Piperacillin-tazobactam
- Pituitary adenomas
- Pituitary apoplexy
- Pituitary imaging, hyperprolactinemia
- Plasma cortisol
- Plasma-free thyroxine (T₄)
- Plasma IGF-1
- Plasma osmolality
- Plasmodium falciparum
- Plasmodium malariae
- Plasmodium ovale
- Platelet function assay-100 (PFA-100)
- Plazomicin
- Pleural sclerosis
- Pleuromutilin
- Pneumatic dilation
- Pneumoconioses
- Pneumonia Severity Index
- Pneumonic plague
- Polyarteritis nodosa (PAN)
- Polyclonal antibodies, solid organ transplantation
- Polycystic kidney disease
- Polyethylene glycol
- Polymeric formulas
- Polymorphic ventricular tachycardia (PMVT)
- Polymyxin B
- Poorly differentiated neuroendocrine carcinoma
- Portal hypertension
- Portal vein thrombosis (PVT)
- Posterior ischemic optic neuropathy (AION)
- Postfibrinolysis care
- Postinfectious glomerulonephropathy
- Postobstructive diuresis
- Postoperative respiratory failure
- Postprandial hypoglycemia
- Postrenal disease
- Post-ST-segment elevation myocardial infarction medical therapy
- Posttransplant lymphoproliferative disease (PTLD)
- Potassium imbalances (disorders)
- Potassium restriction, chronic kidney disease (CKD)
- Potassium-sparing agents
- Potassium-sparing diuretics
- Praziquantel
- Prazosin [table]
- Prednisolone
- Predominantly antibody deficiencies
- Preeclampsia-eclampsia
- Pregabalin, chronic pancreatitis
- Pregnancy test, radioactive iodine (RAI) therapy
- Premeal insulin
- Prerenal azotemia
- Prerenal disease
- Pressure control (PC)
- Pressure-regulated VC ventilation
- Pressure support ventilation (PSV)
- Pretransfusion testing
- Preventive cardiology
- Primary adrenal failure
- Primary biliary cholangitis (PBC)
- Primary ciliary dyskinesia
- Primary eosinophilia
- Primary headache syndromes
- Primary hemostasis
- Primary hyperparathyroidism
- Primary hypothyroidism
- Primary immune thrombocytopenia
- Primary immunodeficiencies (PIDs)
- Primary mineralocorticoid excess
- Primary peritonitis
- Primary pneumothorax
- Primary progressive multiple sclerosis (PPMS)
- Primary prophylaxis
- Primary Raynaud phenomenon (RP)
- Primary sclerosing cholangitis (PSC)
- Primary spontaneous pneumothorax
- Primary syphilis
- Probenecid [table]
- Procainamide [table]
- Procaine PCN G
- Progesterone receptor (PR)
- Programmed cell death 1 (PD-1)
- Progressive multifocal leukoencephalopathy (PML)
- Prolactin
- Prolactin-secreting macroadenomas
- Prominent second heart sound
- Pronouns
- Prophylactic medications, headache treatment
- Propofol [table]
- Propranolol LA [table]
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
- Proptosis
- Prostatic enlargement
- Prostatitis
- Prosthetic valve endocarditis (PVE)
- Protease inhibitors (PIs)
- Protein intake
- Prothrombin complex concentrate
- Prothrombin gene G20210A
- Prothrombin time (PT)
- Proximal lower extremity deep vein thrombosis
- Proximal renal tubular acidosis (RTA)
- Pruritus
- Pseudocysts
- Pseudogout
- Pseudohemoptysis
- Pseudohyperkalemia
- Pseudohyponatremia
- Pseudomembranous colitis
- Pseudomonas aeruginosa
- PTH-related peptide (PTHrP)
- Pulmonary angiography
- Pulmonary aspergillomas
- Pulmonary aspiration
- Pulmonary disease
- Pulmonary embolism (PE)
- Pulmonary infection, nontuberculous mycobacteria
- Pulmonary involvement, diffuse scleroderma
- Pulmonary Langerhans cell histiocytosis (PLCH)
- Pulmonary-renal syndromes
- Pulmonary syndromes, HIV/AIDS
- Pulmonary thromboendarterectomy
- Pulmonary toxicity
- Pulseless disease
- Purulent skin and soft tissue infections
- Push enteroscopy, gastrointestinal bleeding
- Pyridostigmine
- Pyridoxine [table]
- Pyrimethamine
- Pyuria